Clinical and Translational Oncology

Top Research Topics at Clinical & Translational Oncology?

Internal medicine, Oncology, Cancer, Surgery and Cancer research are the subjects of interest in the journal. Most of the Internal medicine studies addressed also intersect with Gastroenterology. Some problems in Oncology that were presented in it overlapped with concepts under Survival rate, Disease, Pathology, Stage (cooking) and Colorectal cancer.

Immunohistochemistry and Carcinoma are among the areas of Pathology tackled. The journal focuses on Cancer but the discussions also offer insight into other areas such as Incidence (epidemiology) and Intensive care medicine. The main emphasis of Clinical & Translational Oncology is the subject of Surgery, focusing on Retrospective cohort study.

Cell culture, Cell growth, Apoptosis, Immunology and Metastasis are some topics wherein Cancer research research discussed in Clinical & Translational Oncology have an impact. Radiation therapy research presented falls under the umbrella topic of Radiology.

• Internal medicine (39.02%)
• Oncology (29.39%)
• Cancer (20.99%)

What are the most cited papers published in the journal?

• Photodynamic therapy of cancer. Basic principles and applications (480 citations)
• Natural products as leads to anticancer drugs. (453 citations)
• Survival in glioblastoma: a review on the impact of treatment modalities. (260 citations)

Research areas of the most cited articles at Clinical & Translational Oncology:

The most cited articles investigate areas of study like Internal medicine, Cancer, Oncology, Cancer research and Pathology. The Internal medicine research presented in the journal articles focuses mostly on Surgery and, on occasion, topics in Quality of life. The published articles explore topics in Oncology which can be helpful for research in disciplines like Clinical trial, Survival rate, Stage (cooking), Colorectal cancer and Prostate cancer.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Gene

The previous edition focused in particular on these issues:

The main points discussed in Clinical & Translational Oncology deals with Internal medicine, Cancer research, Oncology, Cancer and Radiation therapy. It focused on Internal medicine research but expanded to cover Gastroenterology. The Cancer research works featured in the journal incorporate elements from Cell growth, Apoptosis, Downregulation and upregulation, microRNA and Metastasis.

Aside from investigating topics in Lung cancer under Oncology, it also explores concepts in In patient. The study on Cancer presented in the journal intersects with subjects under the field of Incidence (epidemiology). The studies on Radiation therapy discussed can also contribute to research in the domains of Prospective cohort study, Prostate cancer and Toxicity.

The most cited articles from the last journal are:

• A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer. (14 citations)
• Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI1 (12 citations)
• Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Clinical & Translational Oncology (based on the number of publications) are:

• Enrique García Jordá (39 papers) absent at the last edition,
• Alfredo Carrato (33 papers) published 2 papers at the last edition the same number as at the previous edition,
• Eduardo Díaz-Rubio (32 papers) absent at the last edition,
• Emilio Alba (31 papers) absent at the last edition,
• Dolores Isla (31 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical & Translational Oncology (based on the number of publications) are:

• Hospital Universitario La Paz (143 papers) published 24 papers at the last edition, 10 more than at the previous edition,
• University of Barcelona (131 papers) published 15 papers at the last edition the same number as at the previous edition,
• Hospital General Universitario Gregorio Marañón (130 papers) published 12 papers at the last edition, 4 less than at the previous edition,
• Hospital Clínico San Carlos (86 papers) published 5 papers at the last edition, 3 less than at the previous edition,
• Spanish National Research Council (76 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 16.99% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.71% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.49% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.85% of all publications and 45.95% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Background of Journal Authors

Understanding the educational background of authors contributing to the journal can provide insights into the rich diversity of expertise reflected in the studies. It can also shed light on the association between the nature of research topics selected and the author’s academic origin. For example, an author who has completed their research or attributed degree from one of the best nursing schools in California would likely contribute differently to oncology research, than an author who has background in Cell Biology.

The subjects in Clinical & Translational Oncology span across different domains like Cancer research, Oncology, Immunology, and other related fields. Diversity in academic background of authors contributes to more comprehensive and varied discussion on these subjects. Metrics revealing the type and quality of contributing authors’ educational background provide another dimension to understand the substance and authority behind the published content.

A potential future analysis could delve into investigating the correlation between an author's educational background and their specific research focus as well as their publication contribution.